The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States-Reference-Cited by-同舟云学术

The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States

Published:2016-09-07 Issue:1 Volume:20 Page:54-62
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Latremouille-Viau Dominick¹,Chang Jane²,Guerin Annie¹,Shi Sherry¹,Wang Ed²,Yu Justin³,Ngai Christopher²

Affiliation:

1. Analysis Group, Montreal, QC, Canada;

2. Bayer Pharmaceuticals, Whippany, NJ, USA;

3. University of Washington, Seattle, WA, USA;

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1225577

Reference37 articles.

1. Randomized Multicenter Phase II Trial of Bolus Plus Infusional Fluorouracil/Leucovorin Compared With Fluorouracil/Leucovorin Plus Oxaliplatin As Third-Line Treatment of Patients With Advanced Colorectal Cancer

2. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) Research Data (1975-2011), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released May 2014, based on the November 2013 submission. Accessed February 1, 2015

3. Colon Cancer

4. Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular-specific mortality and risk factors in colorectal Cancer patients: A cohort study based on registry data of over 500,000 individuals in the US;Preventive Medicine;2024-02

2. Evaluation and Comparison of Real-World Databases for Conducting Research in Patients With Colorectal Cancer;JCO Clinical Cancer Informatics;2023-07

3. The SLC22A2 gene is a determinant of hematological toxicity of oxaliplatin in patients with colorectal cancer;Int. Journal of Clinical Pharmacology and Therapeutics;2023-01-01

4. Value-Based Analysis of Therapies in Refractory Metastatic Colorectal Cancer in US;Clinical Colorectal Cancer;2022-12

5. Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data;Journal of Cancer Survivorship;2022-11-12